Novel Apoptotic Regulators in Carcinogenesis

Chen, George G. (EDT)/ Lai, Paul B. s. (EDT)

Editore: Springer Verlag, 2012
ISBN 10: 9400749163 / ISBN 13: 9789400749160
Usato / Hardcover / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Our orders are sent from our warehouse locally or directly from our international distributors to allow us to offer you the best possible price and delivery time. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
0 valutazione media
(0 valutazioni)

Riassunto: Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage.

Recensione:

From the reviews:

“This book is appropriate for scientific professionals in the field of basic cancer research, drug development, and cancer medicine, as well as professionals in the pharmaceutical and pharmacological industries. ... This book provides well-summarized information on interesting anticancer agents which have been substantially studied recently on their ability to induce apoptosis in cancer cells. ... The book is a good source of information for the scientific community and medicinal industries who are interested in development of anticancer drugs.” (Qi Chen, Doody’s Review Service, January, 2013)

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Novel Apoptotic Regulators in Carcinogenesis
Casa editrice: Springer Verlag
Data di pubblicazione: 2012
Legatura: Hardcover
Condizione libro: New
Edizione: 1.

I migliori risultati di ricerca su AbeBooks

1.

Springer
Editore: Springer (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Antico o usato Rilegato Quantità: 1
Da
Books Express
(Portsmouth, NH, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2012. Hardcover. Condizione: Good. 2012. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. May be ex-library. Shipping & Handling by region. Buy with confidence, excellent customer service!. Codice articolo 9400749163

Informazioni sul venditore | Contattare il venditore

Compra usato
EUR 91,89
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

2.

Editore: Springer (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Rilegato Quantità: 1
Da
Irish Booksellers
(Portland, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2012. Condizione: New. book. Codice articolo M9400749163

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 134,55
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

3.

Editore: Springer, Netherlands (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Rilegato Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, Netherlands, 2012. Hardback. Condizione: New. 2012 ed.. Language: English . Brand New Book. Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage. Codice articolo LIB9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 155,44
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Editore: Springer, Netherlands (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Rilegato Quantità: 1
Da
Book Depository International
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, Netherlands, 2012. Hardback. Condizione: New. 2012 ed.. Language: English . Brand New Book. Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage. Codice articolo LIB9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 157,31
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

George G. Chen
Editore: Springer (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Quantità: > 20
Print on Demand
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Springer, 2012. HRD. Condizione: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice articolo IQ-9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 177,53
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,27
In U.S.A.
Destinazione, tempi e costi

6.

George G. Chen (editor), Paul B.S. Lai (editor)
Editore: Springer Netherlands 2012-08-21, Dordrecht (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Rilegato Quantità: > 20
Da
Blackwell's
(Oxford, OX, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer Netherlands 2012-08-21, Dordrecht, 2012. hardback. Condizione: New. Codice articolo 9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 189,31
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 6,85
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Chen, George G.
Editore: Springer (2016)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2016. Paperback. Condizione: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice articolo ria9789400749160_lsuk

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 189,39
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,41
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

George G. Chen
Editore: Springer-Verlag Gmbh Aug 2012 (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Quantità: 1
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Aug 2012, 2012. Buch. Condizione: Neu. Neuware - Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage. 299 pp. Englisch. Codice articolo 9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 192,59
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 12,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

9.

George G. Chen
Editore: Springer-Verlag Gmbh Aug 2012 (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Quantità: 1
Da
Rheinberg-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Aug 2012, 2012. Buch. Condizione: Neu. Neuware - Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage. 299 pp. Englisch. Codice articolo 9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 192,59
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,13
Da: Germania a: U.S.A.
Destinazione, tempi e costi

10.

George G. Chen
Editore: Springer-Verlag Gmbh Aug 2012 (2012)
ISBN 10: 9400749163 ISBN 13: 9789400749160
Nuovo Quantità: 1
Da
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Aug 2012, 2012. Buch. Condizione: Neu. Neuware - Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage. 299 pp. Englisch. Codice articolo 9789400749160

Informazioni sul venditore | Contattare il venditore

Compra nuovo
EUR 192,59
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,13
Da: Germania a: U.S.A.
Destinazione, tempi e costi

Vedi altre 7 copie di questo libro

Vedi tutti i risultati per questo libro